loading

Puma Biotechnology Inc Aktie (PBYI) Neueste Nachrichten

pulisher
Apr 28, 2025

Puma Biotechnology Presents Clinical Data on Neratinib at the AACR Annual Meeting 2025 - Yahoo Finance

Apr 28, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 25, 2025

Puma Biotechnology to Host Conference Call to Discuss First Quarter 2025 Financial Results - BioSpace

Apr 25, 2025
pulisher
Apr 23, 2025

Should Value Investors Buy Puma Biotechnology (PBYI) Stock? - Yahoo Finance

Apr 23, 2025
pulisher
Apr 22, 2025

Puma Biotechnology Stock Rises 35% in 6 Months: Here's Why - MSN

Apr 22, 2025
pulisher
Apr 21, 2025

Is The Options Market Predicting A Spike In Puma Biotechnology Stock? - Barchart.com

Apr 21, 2025
pulisher
Apr 21, 2025

Is the Options Market Predicting a Spike in Puma Biotechnology Stock? - Yahoo Finance

Apr 21, 2025
pulisher
Apr 11, 2025

Puma Biotechnology: Initiating Hold Rating With Limited Near-Term Upside And Uncertain Pipeline Potential - Seeking Alpha

Apr 11, 2025
pulisher
Apr 03, 2025

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)April 2, 2025 - BioSpace

Apr 03, 2025
pulisher
Apr 02, 2025

Puma Biotech Expands Team: New Hires Receive Strategic Stock Compensation Package - Stock Titan

Apr 02, 2025
pulisher
Mar 29, 2025

Further weakness as Puma Biotechnology (NASDAQ:PBYI) drops 11% this week, taking five-year losses to 55% - simplywall.st

Mar 29, 2025
pulisher
Mar 27, 2025

Puma Biotechnology, Inc. (NASDAQ:PBYI) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? - Yahoo Finance

Mar 27, 2025
pulisher
Mar 26, 2025

Puma Biotechnology to Present Clinical Data on Neratinib at the AACR Annual Meeting 2025 - BioSpace

Mar 26, 2025
pulisher
Mar 26, 2025

Groundbreaking Clinical Trial: Neratinib's Novel Combination Approach Targets HER2 Tumors - Stock Titan

Mar 26, 2025
pulisher
Mar 19, 2025

Puma Biotechnology Stock Rises 24% in 3 Months: Here's Why - MSN

Mar 19, 2025
pulisher
Mar 19, 2025

Why Investors Are Buzzing About Puma Biotechnology’s Earnings: Unpacking the Details - procarsrl.com.ar

Mar 19, 2025
pulisher
Mar 19, 2025

Puma Biotechnology (NASDAQ:PBYI) Stock Crosses Above Two Hundred Day Moving Average – Here’s What Happened - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

Puma Biotechnology (PBYI): One of the Best Short-Term Stocks to Buy Right Now - MSN

Mar 18, 2025
pulisher
Mar 15, 2025

10 Best Short-Term Stocks to Buy Now with Rebound Potential - Insider Monkey

Mar 15, 2025
pulisher
Mar 12, 2025

Checking in on Puma Biotechnology Inc (PBYI) after recent insiders movement - Knox Daily

Mar 12, 2025
pulisher
Mar 11, 2025

Rhumbline Advisers Lowers Holdings in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Puma Biotechnology, Inc. (NASDAQ:PBYI) Held Back By Insufficient Growth Even After Shares Climb 26% - Simply Wall St

Mar 10, 2025
pulisher
Mar 10, 2025

Puma Biotechnology (NASDAQ:PBYI) Rating Lowered to Buy at StockNews.com - Armenian Reporter

Mar 10, 2025
pulisher
Mar 08, 2025

Puma Biotechnology (NASDAQ:PBYI) Stock Rating Lowered by StockNews.com - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

We Think Puma Biotechnology's (NASDAQ:PBYI) Healthy Earnings Might Be Conservative - Yahoo Finance

Mar 07, 2025
pulisher
Mar 06, 2025

Puma Biotech grants stock award to new hire By Investing.com - Investing.com India

Mar 06, 2025
pulisher
Mar 05, 2025

Puma Biotechnology, Inc. to Host Earnings Call - ACCESS Newswire

Mar 05, 2025
pulisher
Mar 05, 2025

Puma Biotechnology to Present at Barclays 27th Annual Global Healthcare Conference - BioSpace

Mar 05, 2025
pulisher
Mar 05, 2025

Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference - BioSpace

Mar 05, 2025
pulisher
Mar 05, 2025

Puma Biotech grants stock award to new hire - Investing.com

Mar 05, 2025
pulisher
Mar 05, 2025

Can Puma Biotechnology's Conference Presentation Signal New Growth Opportunities? - StockTitan

Mar 05, 2025
pulisher
Mar 04, 2025

Puma Biotechnology’s Earnings Call: Mixed Sentiments and Future Outlook - MSN

Mar 04, 2025
pulisher
Mar 03, 2025

Puma Biotechnology’s (PBYI) Buy Rating Reiterated at HC Wainwright - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

Results: Puma Biotechnology, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo

Mar 02, 2025
pulisher
Feb 28, 2025

PBYI Stock Rises as Q4 Earnings & Sales Outpace Estimates - Nasdaq

Feb 28, 2025
pulisher
Feb 28, 2025

Puma Biotechnology: Strong Financial Performance and Strategic Developments Justify Buy Rating - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

GoodRx Holdings Leads The Charge With These 3 Promising Penny Stocks - Simply Wall St

Feb 28, 2025
pulisher
Feb 28, 2025

Puma Biotechnology Inc (PBYI) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada

Feb 28, 2025
pulisher
Feb 28, 2025

Puma Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results - sharewise

Feb 28, 2025
pulisher
Feb 27, 2025

Puma Biotechnology Reports Strong Earnings Growth in 2024 - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Puma Biotech: Q4 Earnings Snapshot - CTPost

Feb 27, 2025
pulisher
Feb 27, 2025

Puma Biotechnology: Hold Rating Amidst Flat Sales Growth and Uncertain Drug Prospects - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Puma Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings call transcript: Puma Biotech Q4 2024 beats earnings expectations By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 27, 2025

Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance

Feb 27, 2025
$20.90
price up icon 1.36%
$69.80
price up icon 0.31%
$32.42
price down icon 0.60%
$24.00
price up icon 0.25%
$103.85
price down icon 0.51%
biotechnology ONC
$249.09
price down icon 0.47%
Kapitalisierung:     |  Volumen (24h):